CAL
INFI

Capital Advisors Ltd’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Capital Advisors Ltd’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-150
Closed – – 1619
2022
Q2 		$0 Buy
+150
New +$115 ﹤0.01% 1422

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Advisors Ltd's INFI Position: Q3 2022 in Review

Capital Advisors Ltd sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 150 shares.

Capital Advisors Ltd first reported a position in INFI in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • Capital Advisors Ltd reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Capital Advisors Ltd sold 150 Infinity Pharmaceuticals, Inc. shares in Q3 2022.
  • Capital Advisors Ltd first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2022 and held it in 1 quarter.
  • Capital Advisors Ltd's Infinity Pharmaceuticals, Inc. position peaked at $0 in Q2 2022.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Capital Advisors Ltd's 13F filing for Q3 2022, filed 9 Nov 2022.